Renaissance Technologies’s BioDelivery Sciences International, Inc. BDSI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-304,500
| Closed | -$944K | – | 4677 |
|
|
2021
Q4 | $944K | Buy |
304,500
+123,300
| +68% | +$415K | ﹤0.01% | 2689 |
|
|
2021
Q3 | $654K | Sell |
181,200
-70,826
| -28% | -$267K | ﹤0.01% | 2772 |
|
|
2021
Q2 | $902K | Buy |
252,026
+76,726
| +44% | +$271K | ﹤0.01% | 2720 |
|
|
2021
Q1 | $685K | Sell |
175,300
-140,600
| -45% | -$581K | ﹤0.01% | 2787 |
|
|
2020
Q4 | $1.33M | Sell |
315,900
-217,119
| -41% | -$837K | ﹤0.01% | 2356 |
|
|
2020
Q3 | $1.99M | Sell |
533,019
-178,844
| -25% | -$761K | ﹤0.01% | 2141 |
|
|
2020
Q2 | $3.1M | Buy |
711,863
+33,463
| +5% | +$150K | ﹤0.01% | 1918 |
|
|
2020
Q1 | $2.57M | Sell |
678,400
-432,951
| -39% | -$2.13M | ﹤0.01% | 1924 |
|
|
2019
Q4 | $7.02M | Buy |
1,111,351
+966,651
| +668% | +$5.68M | 0.01% | 1662 |
|
|
2019
Q3 | $609K | Sell |
144,700
-87,800
| -38% | -$375K | ﹤0.01% | 2798 |
|
|
2019
Q2 | $1.08M | Sell |
232,500
-151,500
| -39% | -$705K | ﹤0.01% | 2640 |
|
|
2019
Q1 | $2.04M | Buy |
+384,000
| New | +$1.75M | ﹤0.01% | 2298 |
|
|
2018
Q4 | – | Sell |
-98,516
| Closed | -$276K | – | 3830 |
|
|
2018
Q3 | $276K | Sell |
98,516
-68,263
| -41% | -$192K | ﹤0.01% | 3045 |
|
|
2018
Q2 | $492K | Buy |
166,779
+113,779
| +215% | +$270K | ﹤0.01% | 2839 |
|
|
2018
Q1 | $119K | Sell |
53,000
-404,900
| -88% | -$948K | ﹤0.01% | 3250 |
|
|
2017
Q4 | $1.35M | Sell |
457,900
-127,300
| -22% | -$352K | ﹤0.01% | 2541 |
|
|
2017
Q3 | $1.73M | Buy |
585,200
+94,500
| +19% | +$288K | ﹤0.01% | 2352 |
|
|
2017
Q2 | $1.37M | Buy |
490,700
+337,900
| +221% | +$713K | ﹤0.01% | 2448 |
|
|
2017
Q1 | $290K | Buy |
+152,800
| New | +$295K | ﹤0.01% | 2917 |
|
|
2016
Q4 | – | Sell |
-929,275
| Closed | -$2.51M | – | 3692 |
|
|
2016
Q3 | $2.51M | Sell |
929,275
-784,325
| -46% | -$1.99M | ﹤0.01% | 2051 |
|
|
2016
Q2 | $4.04M | Buy |
1,713,600
+1,080,500
| +171% | +$2.98M | 0.01% | 1740 |
|
|
2016
Q1 | $2.04M | Buy |
633,100
+399,000
| +170% | +$1.47M | ﹤0.01% | 2205 |
|
|
2015
Q4 | $1.12M | Buy |
+234,100
| New | +$1.33M | ﹤0.01% | 2412 |
|
|
2014
Q4 | – | Sell |
-230,800
| Closed | -$3.94M | – | 3327 |
|
|
2014
Q3 | $3.94M | Buy |
230,800
+24,338
| +12% | +$353K | 0.01% | 1285 |
|
|
2014
Q2 | $2.49M | Buy |
+206,462
| New | +$1.96M | 0.01% | 1612 |
|
Other funds holding BDSI
Renaissance Technologies's BDSI Position: Q1 2022 in Review
Renaissance Technologies sold out of BioDelivery Sciences International, Inc. (BDSI) in Q1 2022, closing a stake of 304,500 shares — an estimated $944K sold.
Renaissance Technologies first reported a position in BDSI in Q2 2014 and held it in 25 quarters. The position peaked at $7.02M in Q4 2019. 2 funds tracked by Wall St. Rank hold BDSI as of Q1 2022.
- Renaissance Technologies reported no remaining BioDelivery Sciences International, Inc. position as of Q1 2022 after selling out during the quarter.
- Renaissance Technologies sold 304,500 BioDelivery Sciences International, Inc. shares in Q1 2022, an estimated $944K.
- Renaissance Technologies first reported a position in BioDelivery Sciences International, Inc. in Q2 2014 and held it in 25 quarters.
- Renaissance Technologies's BioDelivery Sciences International, Inc. position peaked at $7.02M in Q4 2019.
- 2 funds tracked by Wall St. Rank held BioDelivery Sciences International, Inc. as of Q1 2022.
Based on Renaissance Technologies's 13F filing for Q1 2022, filed 13 May 2022.